Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Thomas Cars"'
Autor:
Johan Sundström, Johan Ärnlöv, Stelios Karayiannides, Johan Bodegard, Karolina Ersmark, Stefan Gustafsson, Thomas Cars, Maria K. Svensson, Anna Norhammar
Publikováno v:
ESC Heart Failure, Vol 11, Iss 3, Pp 1377-1388 (2024)
Abstract Aims This study aimed to characterize a contemporary population with subtypes of incident or prevalent heart failure (HF) based on reduced (HFrEF), mildly reduced, or preserved (HFpEF) left ventricular ejection fraction (LVEF) and to assess
Externí odkaz:
https://doaj.org/article/899c8b0a6e57407cb92948c2e9448a93
Autor:
Maria K. Svensson, Stefan James, Annica Ravn-Fischer, Guillermo Villa, Lovisa Schalin, Thomas Cars, Stefan Gustafsson, Emil Hagström
Publikováno v:
Upsala Journal of Medical Sciences, Vol 129, Pp 1-10 (2024)
Background: Treatment with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors reduces low-density lipoprotein cholesterol (LDL-C) levels and decreases the incidence of major ischaemic events in clinical trials. However, less is known ab
Externí odkaz:
https://doaj.org/article/6a82235f13f94afb98a696585deb3a07
Autor:
Johan Ärnlöv, Johan Bodegård, Johan Sundström, Thomas Cars, Stelios Karayiannides, Anna Norhammar, Maria Eriksson Svensson, Stefan Gustafsson
Publikováno v:
BMJ Open, Vol 14, Iss 4 (2024)
Objectives Identify the windows of opportunity for the diagnosis of chronic kidney disease (CKD) and the prevention of its adverse outcomes and quantify the potential population gains of such prevention.Design and setting Observational, population-wi
Externí odkaz:
https://doaj.org/article/497edc95af22441f9ab57b5586207ef9
Autor:
Malin Christersson, Stefan Gustafsson, Erik Lampa, Matilda Almstedt, Thomas Cars, Johan Bodegård, Gabriel Arefalk, Johan Sundström
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 8 (2024)
Background Heart failure guidelines have recently introduced a narrow category with mildly reduced left ventricular ejection fraction (LVEF) (heart failure with mildly reduced ejection fraction; LVEF 41%–49%) between the previous categories of redu
Externí odkaz:
https://doaj.org/article/a4c25dea28b44ebc90a1691cc8fde97d
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 15 (2021)
Background Considering the widespread risk of collider bias and confounding by indication in previous research, the associations between renin‐angiotensin aldosterone system (RAAS) inhibitor use and COVID‐19 remain unknown. Accordingly, this stud
Externí odkaz:
https://doaj.org/article/08bad1f6fdfb4908b3eb7acf95f6e9ab
Publikováno v:
Upsala Journal of Medical Sciences, Vol 124, Iss 1, Pp 46-50 (2019)
In order to monitor the net public health benefit of new drugs, especially in the light of recent stepwise approval approaches, there is a need to optimize real-time post-marketing evaluation of new drugs using data collected in routine care. Sweden,
Externí odkaz:
https://doaj.org/article/d66a547c333041069cde5192dc71982e
Autor:
Johan, Lundberg, Thomas, Cars, Sven-Åke, Lööv, Jonas, Söderling, Johan, Sundström, Jari, Tiihonen, Amy, Leval, Anna, Gannedahl, Carl, Björkholm, Mikael, Själin, Clara, Hellner
Publikováno v:
JAMA psychiatry.
The totality of the societal and individual impact of treatment-resistant depression (TRD) is unknown, as is the potential to prognosticate TRD. The generalizability of many observational studies on TRD is limited.To estimate the burden of TRD in a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5aea52a88407afdd9d70707af12aa83d
https://pubmed.ncbi.nlm.nih.gov/36515938
https://pubmed.ncbi.nlm.nih.gov/36515938
Autor:
Johan Lundberg, Thomas Cars, Sven‐Åke Lööv, Jonas Söderling, Jari Tiihonen, Amy Leval, Anna Gannedahl, Carl Björkholm, Mikael Själin, Clara Hellner
Objective Major depressive disorder (MDD) is a highly prevalent condition and a significant contributor to global disability. The vast majority of MDD is handled by primary care, but most real-life studies on MDD only include data from secondary care
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::471842df60b6bf8106a4d95fdcf1b8a2
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485445
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485445
Autor:
Bo Freyschuss, Maria K. Svensson, Thomas Cars, Lars Lindhagen, Helena Johansson, Andreas Kindmark
Publikováno v:
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 37(4)
Results from real-world evidence (RWE) from the largest healthcare region in Sweden show low uptake of antiresorptive (AR) treatment, but beneficial effect in those receiving treatment, especially for the composite outcome of hip fracture or death. F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477f70015c2597aa1b327a36c8762bab
https://pubmed.ncbi.nlm.nih.gov/34984745
https://pubmed.ncbi.nlm.nih.gov/34984745